40^th European Cardiology Conference

Cardio-Metabolic Disease Management

Cardio-Metabolic Disease Management examines the interconnected nature of metabolic disorders—including diabetes, obesity, and dyslipidemia—and their significant impact on cardiovascular health. This content highlights advanced diagnostics, personalized treatment plans, and innovative therapies designed to manage complex metabolic profiles. Pharmacological advancements, such as SGLT2 inhibitors and GLP-1 receptor agonists, play a key role in reducing cardiovascular risk. The section also explores lifestyle interventions, nutritional strategies, and behavioral modifications that improve metabolic balance. Integrated care models combining endocrinology and cardiology are essential for effective management of high-risk patients. Predictive analytics and biomarker-driven approaches enhance early identification of cardio-metabolic complications. Emerging research on inflammation, insulin resistance, and hormonal influences provides deeper understanding of disease mechanisms. Overall, this session underscores how comprehensive management strategies, improved diagnostics, and innovative therapies are essential for reducing cardiovascular complications associated with metabolic disorders.